CytomX Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,143.00
30,310.00
35,374.00
58,900.00
43,099.00
84,604
Depreciation, Depletion & Amortization
655.00
783.00
1,206.00
1,733.00
1,645.00
1,884
Other Funds
512.00
648.00
6,993.00
11,869.00
22,375.00
15,177
Funds from Operations
13,966.00
28,871.00
27,167.00
45,292.00
19,592.00
67,543
Changes in Working Capital
5,958.00
60,673.00
248.00
43,260.00
189,965.00
7,978
Net Operating Cash Flow
8,008.00
31,802.00
27,415.00
2,032.00
170,373.00
75,521
Capital Expenditures
732.00
1,663.00
1,594.00
2,176.00
1,559.00
Sale of Fixed Assets & Businesses
-
-
-
52.00
-
Purchase/Sale of Investments
-
-
128,968.00
47,983.00
119,707.00
Net Investing Cash Flow
732.00
1,663.00
130,562.00
45,859.00
121,266.00
Issuance/Reduction of Debt, Net
2,635.00
1,256.00
3,067.00
66.00
-
Net Financing Cash Flow
2,697.00
25,554.00
153,403.00
996.00
23,796.00
Net Change in Cash
6,043.00
55,693.00
4,574.00
44,823.00
72,903.00
Free Cash Flow
8,740.00
30,139.00
29,009.00
4,208.00
168,814.00
Deferred Taxes & Investment Tax Credit
10.00
8.00
8.00
6.00
513.00
-
Change in Capital Stock
62.00
26,810.00
156,470.00
930.00
23,796.00
About CytomX Therapeutics
View Profile
